Destination therapy in late-stage heart failure
- 1 March 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Coronary Artery Disease
- Vol. 15 (2) , 87-90
- https://doi.org/10.1097/00019501-200403000-00003
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- The Registry Of The International Society For Heart And Lung Transplantation: Nineteenth Official Report—2002The Journal of Heart and Lung Transplantation, 2002
- Emergence of Laplace Therapeutics: Declaring an End to “End‐Stage” Heart FailureCongestive Heart Failure, 2002
- Update on left ventricular assist devices as a bridge to recoveryCurrent Opinion in Organ Transplantation, 2001
- Chronic Unloading by Left Ventricular Assist Device Reverses Contractile Dysfunction and Alters Gene Expression in End-Stage Heart FailureCirculation, 2000
- Left ventricular assist device implantation augments nitric oxide dependent control of mitochondrial respiration in failing human heartsJournal of the American College of Cardiology, 2000
- Alterations in Ca2+ cycling proteins and Gαq signaling after left ventricular assist device support in failing human heartsCardiovascular Research, 2000
- Regression of Cellular Hypertrophy After Left Ventricular Assist Device SupportCirculation, 1998
- Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failureThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Myocyte Recovery After Mechanical Circulatory Support in Humans With End-Stage Heart FailureCirculation, 1998
- Effect of the Implantable Left Ventricular Assist Device on Neuroendocrine Activation in Heart FailureCirculation, 1995